PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.520.06 (-1.08%)
5.46 - 5.56
4.95 - 8.28
1.7K / 2.4K (Avg.)
-276.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.27%
Positive revenue growth while STERV.HE is negative. John Neff might see a notable competitive edge here.
145.19%
Gross profit growth above 1.5x STERV.HE's 13.83%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
543.28%
EBIT growth above 1.5x STERV.HE's 326.32%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
543.28%
Operating income growth above 1.5x STERV.HE's 326.32%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
380.33%
Net income growth above 1.5x STERV.HE's 203.20%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
411.36%
EPS growth above 1.5x STERV.HE's 200.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
411.36%
Diluted EPS growth above 1.5x STERV.HE's 200.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-6.09%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-6.09%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-56.26%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-83.99%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-14.10%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-15.06%
Negative 5Y CAGR while STERV.HE stands at 6.90%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-9.93%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
572.66%
Positive long-term OCF/share growth while STERV.HE is negative. John Neff would see a structural advantage in sustained cash generation.
173.52%
Positive OCF/share growth while STERV.HE is negative. John Neff might see a comparative advantage in operational cash viability.
8.39%
Positive 3Y OCF/share CAGR while STERV.HE is negative. John Neff might see a big short-term edge in operational efficiency.
125.94%
Similar net income/share CAGR to STERV.HE's 127.96%. Walter Schloss would see parallel tailwinds or expansions for both firms.
50.00%
5Y net income/share CAGR above 1.5x STERV.HE's 27.09%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
282.40%
3Y net income/share CAGR above 1.5x STERV.HE's 76.71%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
-4.37%
Negative 5Y equity/share growth while STERV.HE is at 2.49%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
19.97%
Positive short-term equity growth while STERV.HE is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
No Data
No Data available this quarter, please select a different quarter.
34.60%
AR growth well above STERV.HE's 28.95%. Michael Burry fears inflated revenue or higher default risk in the near future.
4.72%
Inventory shrinking or stable vs. STERV.HE's 16.19%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
6.86%
Asset growth above 1.5x STERV.HE's 3.16%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
18.20%
BV/share growth above 1.5x STERV.HE's 5.62%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.72%
Debt growth far above STERV.HE's 0.87%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
4.05%
SG&A growth well above STERV.HE's 3.88%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.